Consequences of current lipid guidelines for the Federal Republic of Germany

Springer Science and Business Media LLC - Tập 68 - Trang 454-459 - 1990
L. Kohlmeier1, H. Hoffmeister1
1Institut für Sozialmedizin und Epidemiologie des Bundesgesundheitsamtes, Berlin

Tóm tắt

According to the results of the first nationally representative population study in the Federal Republic of Germany (FRG) conducted in 1984–1986, a vast majority of the population have elevated cholesterol levels and undesirable low density lipoprotein (LDL) cholesterol levels. This problem increases with age in two dimensions, more individuals become hyperlipemic and those who were hyperlipemic develop more extreme pathologic values. Preliminary analyses suggest that the national profile in the FRG is worse than that of the USA. Based on the current recommendations of the national cholesterol education program of the USA, 23 million adults in the FRG should be receiving dietary advice for elevated lipid levels and 18 million persons should be in regular treatment programs. Consequently, implementation of such a national strategy and program would require the assembly and training of an adequate professional body of physicians and support staff in the diagnosis and treatment of hyperlipidemias.

Tài liệu tham khảo

Blackburn H (1988) The Evaluation of mass atherosclerotic disease: the rationale for primary prevention. Ann Clin Res 20:4–9

Block L, Banspach SW, Gans K, Harris C, Lasater TM, Lefebvre C, Carleton RA (1988) Impact of public education and continuing medical education on physician attitudes and behavior concerning cholesterol. Am J Prev Med 4:255–260

Delong DM, Delong ER, Wood PD, Lippel K, Rifkind BM (1986) A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The lipid Research Clinics Prevalence Study. JAMA 256:2372–2377

Deutsche Herz-Kreislauf-Präventionsstudie (1989) Vorsorge gegen Herz-Kreislauf-Krankheiten: Beiträge der Forschung. Programmreport 1989, Design; Methoden, Ergebnisse zur Studienmitte. Der Bundesminister für Forschung Technologie, Bonn

European Atherosclerosis Society (1988) Strategies for the prevention of coronary heart disease; a policy statement for the European Atherosclerosis Society. Eur Heart J 8:77–88

Expert Panel (1988) Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36–69

Friedewald WT, Levy RI, Frederickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

GCP Study Group (1988) The German Cardiovascular Prevention Study (GCP): design and methods. Eur Heart J 10:1058–1066

Henke K-D, Behrens C, Arab L, Schlierf G (1986) Die Kosten ernährungsbedingter Krankheiten. Band 179 der Schriftenreihe des Bundesministers für Jugend, Familie, Frauen und Gesundheit. Kohlhammer, Stuttgart

Hoffmeister H, Junge B (1988) Mortalität an ernährungsbedingten Krankheiten. Ernährungsbericht 1988. Deutsche Gesellschaft für Ernährung, Frankfurt am Main

Hoffmeister H, Hoeltz J, Schön D, Schröder E, Güther B (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP Band I DHP Forum, Deutsche Herz-Kreislauf-Präventionsstudie

Hoffmeister H, Stolzenberg H, Schön D, Thefeld W, Hoeltz J, Schröder E (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP Band II DHP Forum, Deutsche Herz-Kreislauf-Präventionsstudie

Junge B (1985) Decline in mortality in Japan, USA and the Federal Republic of Germany — the contribution of the specific causes of death. Klin Wochenschr 63:793–801

Laemmle P, Unger L, McCray C, Geisler M, Chalin M, Hardy RI, Glueck CJ (1988) Know your cholesterol: population screening. J Lab Clin Med 112:567–574

Leaf A (1989) Management of hypercholesterilemia. Are preventive interventions advisable? N Engl J Med 321:680–684

National Center for Health Statistics (1986) Total serum cholesterol levels of adults 20–74 years of age: United States. 1976–1980. Vital and health statistics, Ser II, no 236. Department of Health and Human Services publication (PHS) 86-1686, Government Printing Office, Washington, D.C.

Rästram L, Luepker RV, Pirie PL (1988) Effects of screening and referral on follow-up and treatment of high blood cholesterol levels. Am J Prev Med 4:244–248

Schucker B, Wittes JT, Cutler JA, Bailey K, Mackintosh DR, Gordon DJ, Haines CM, Mattson ME, Goor RS, Rifkind BM (1987) Change in physician perspective on cholesterol and heart disease. JAMA 258:3521–3526

Statistisches Bundesamt (1988) Statistisches Jahrbuch 1988 für die Bundesrepublik Deutschland. Kohlhammer, Stuttgart

WHO Expert Committee (1986) Community prevention and control of cardiovascular diseases. Technical report series 732. WHO, Geneva

Wilson PWF, Christiansen JC, Anderson KM, Kannel WB (1989) Impact of national guidelines for cholesterol risk factor screening. JAMA 262:41–44

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 68

454-459

Thông tin tác giả